Effectiveness of diagnostic and active detection of arterial hypertension and blood pressure control in an organized population under martial law in Ukraine – the «Strong Hearts» Program
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
https://orcid.org/0000-0002-3925-2948
Abstract
The aim – to evaluate the effectiveness of identifying patients with hypertension using an active diagnosis system and to evaluate the effectiveness of providing care using a medical assistant and using various information services.
Materials and methods. The study included a total of 1425 participants, 61.75 % women and 38.25 % men, who agreed to participate in the active hypertension diagnostics system. The largest proportion was made up of participants aged 30 to 59 years – 67.30 %. 1261 (88.49 %) of the examined underwent laboratory examination, and 11.51 % of the respondents refused to undergo a free laboratory examination. 85.54 % of the examined visited a specialist, and 14.46 % refused a consultation. Drugs and all examinations were free of charge. Less than half (48.49 %) of the patients agreed to treatment.
Results. 54.32 % of the patients were diagnosed with hypertension. The drugs were dispensed through pharmacy chains. 493 patients (71.35 %) applied to receive free drugs within the 2nd visit to pharmacies. At the 3rd visit, 387 patients (56.00 %) received medication, at the 4th visit – 307 patients (44.43 %), at the 5th visit – 193 patients (27.93 %), and at the 6th visit – 88 patients (12.73 %). As a result of the program, all participants, both healthy and with detected hypertension, showed an improvement in adherence to a healthy lifestyle, with improved nutrition, increased physical activity, and a decrease in harmful habits. Constant communication between health care providers and program participants had a positive impact on program participants, and the main wish was more live communication and care calls.
Conclusion. This program is an example of an attempt to build a system of active detection, control, and long-term observation in an organized population and has proven the positive role of others, in addition to doctors, healthcare providers, in identifying and improving the adherence of patients with hypertension to treatment.
Article Details
Keywords:
References
Beaney T, Wang W, Schlaich MP, et al. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign. J Hypertens. 2023;41(9):1446-1455. https://doi.org/10.1097/HJH.0000000000003488
Dixon DL, Salgado TM, Caldas LM, Van Tassell BW, Sisson EM. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists. J Am Pharm Assoc (2003). 2018;58(4):382-386. https://doi.org/10.1016/j.japh.2018.04.027
Gona OJ, Madhan R, Shambu SK. Assessment of Clinical Pharmacists’ Assistance for Patients With Established Cardiovascular Diseases During the COVID-19 Pandemic: Insights From Southern India. Front Cardiovasc Med. 2020;7:599807. Published 2020 Dec 3. https://doi.org/10.3389/fcvm.2020.599807
Onakomaiya D, Cooper C, Barber A, et al. Strategies to Improve Medication Adherence and Blood Pressure Among Racial/Ethnic Minority Populations: A Scoping Review of the Literature from 2017 to 2021. Curr Hypertens Rep. 2022;24(12):639-654. https://doi.org/10.1007/s11906-022-01224-2
McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension [published correction appears in Eur Heart J. 2025 Apr 7;46(14):1300. Eur Heart J. 2024;45(38):3912-4018. https://doi.org/10.1093/eurheartj/ehae178
Gupta J, Dalpe J, Kanselaar S, et al. Ea$ing into the USA: study protocol for adapting the Economic and Social Empowerment (EA$E) intervention for US-based, forcibly based populations. BMJ Open. 2023;13(4):e069069. Published 2023 Apr 3. https://doi.org/10.1136/bmjopen-2022-069069
Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich). 2012;14(1):51-65. https://doi.org/10.1111/j.1751-7176.2011.00542.x
Chonko K, Axtell S, Mayzel B. Pharmacist Hypertension Management Quality Review at an Ambulatory Care Clinic. J Pharm Technol. 2022;38(1):31-38. https://doi.org/10.1177/87551225211064240
Delage C, Lelong H, Brion F, Blacher J. Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia. Eur J Hosp Pharm. 2021;28(Suppl 2):e197-e202. https://doi.org/10.1136/ejhpharm-2021-002787
Mostarac I, Atzema CL. High blood pressure readings on in-store machines: a qualitative study of the perspective of pharmacy staff. J Pharm Policy Pract. 2021;14(1):13. Published 2021 Feb 1. https://doi.org/10.1186/s40545-021-00297-9
Patti M, Colmenares EW, Abrahamson A, et al. Impact of pharmacist participation in the patient care team on value-based health measures. Am J Health Syst Pharm. 2022;79(19):1645-1651. https://doi.org/10.1093/ajhp/zxac175
Wagner TD, Jones MC, Salgado TM, Dixon DL. Pharmacist’s role in hypertension management: a review of key randomized controlled trials. J Hum Hypertens. 2020;34(7):487-494. https://doi.org/10.1038/s41371-020-0331-7
Waszyk-Nowaczyk M, Guzenda W, Plewka B, et al. Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension. J Clin Med. 2020;9(8):2572. Published 2020 Aug 8. https://doi.org/10.3390/jcm9082572
Waszyk-Nowaczyk M, Jasińska-Stroschein M, Dymek J, et al. The Critical Role of Community Pharmacists in Blood Pressure Monitoring. Med Sci Monit. 2024;30:e944657. Published 2024 Aug 15. https://doi.org/10.12659/MSM.944657
Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) [published correction appears in J Hypertens. 2024 Jan 1;42(1):194. https://doi.org/10.1097/HJH.0000000000003621.]. J Hypertens. 2023;41(12):1874-2071. https://doi.org/10.1097/HJH.0000000000003480
Niklas A, Flotyńska A, Puch-Walczak A, et al. Prevalence, awareness, treatment and control of hypertension in the adult Polish population – Multi-center National Population Health Examination Surveys – WOBASZ studies. Arch Med Sci. 2018;14(5):951-961. https://doi.org/10.5114/aoms.2017.72423
Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Arterial hypertension. Lancet. 2021;398(10296):249-261. https://doi.org/10.1016/S0140-6736(21)00221-X
Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238-1247. https://doi.org/10.1111/bcp.12452
Nakanishi M, Mizuno T, Mizokami F, et al. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials. J Clin Pharm Ther. 2021;46(1):114-120. https://doi.org/10.1111/jcpt.13262
Treciokiene I, Postma M, Nguyen T, et al. Healthcare professional-led interventions on lifestyle modifications for hypertensive patients – a systematic review and meta-analysis. BMC Fam Pract. 2021;22(1):63. Published 2021 Apr 5. https://doi.org/10.1186/s12875-021-01421-z
Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387-397. https://doi.org/10.1111/ijpp.12462
Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718. Published 2014 Apr 10. https://doi.org/10.1161/JAHA.113.000718